Dr. Oveisi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
127 S San Vicente Blvd
Floor 7
Los Angeles, CA 90048Phone+1 310-423-1825Fax+1 310-423-1977
Summary
- David Oveisi, MD, is a Hematologist based in Los Angeles, California, with a subspecialty in Hematologic Oncology. He completed his education at reputed institutions like the UCLA David Geffen School of Medicine/UCLA Medical Center and Uconn School of Medicine. Currently, Dr.Oveisi is employed as a Staff Physician at the Cedars-Sinai Medical Center. His areas of expertise include conditions like amyloidosis and multiple myeloma, and procedures such as stem cell transplantation. He has published multiple articles in reputable journals and was also awarded as the Chief Fellow in Hematology and Oncology from Olive View-UCLA Medical Center in 2021-2022.
Education & Training
Olive View/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 2017 - 2019- UCLA David Geffen School of Medicine/UCLA Medical CenterInternship, Internal Medicine, 2016 - 2017
Uconn School Of MedicineClass of 2016
University of California San DiegoBS, 2007 - 2011
Certifications & Licensure
CA State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Chief Fellow, Hematology and Oncology Olive View-UCLA Medical Center, 2021-2022
Clinical Trials
- A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma Start of enrollment: 2023 Jan 26
Publications & Presentations
PubMed
- Irradiated Bone Marrow Volume is Associated With Hematologic Toxicity in Patients With Multiple Myeloma.Samuel C Zhang, Sungjin Kim, Jennifer Steers, Bradley Stiehl, Katrina D Silos
International Journal of Radiation Oncology, Biology, Physics. 2024-10-28 - Secondary B-cell acute lymphoblastic leukaemia in a patient with multiple myeloma.Benjamin Puliafito, David Oveisi, Christina Fanous, Monica El-Masry
BMJ Case Reports. 2022-06-22 - 1 citationsDisease characteristics of diffuse large B‐cell lymphoma predicting relapse and survival after autologous stem cell transplantation: A single institution experienceDaria Gaut, Tahmineh Romero, David Oveisi, Grant Howell, Gary J. Schiller
Hematological Oncology. 2020-02-01
Committees
- Member, Data Safety and Monitoring Committee 2023 - Present
Professional Memberships
- Member
- Member
- Member
- International Myeloma SocietyMember
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
